Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study.

Laviola, Luigi; Porcellati, Francesca; Bruttomesso, Daniela; Larosa, Monica; Rossi, Maria Chiara; Nicolucci, Antonio

Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study.

Laviola, Luigi; Porcellati, Francesca; Bruttomesso, Daniela; Larosa, Monica; Rossi, Maria Chiara; Nicolucci, Antonio.

Afiliação

Laviola L; Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
Porcellati F; Section of Internal Medicine, Endocrinology and Metabolism, Department of Medicine, Perugia University School of Medicine, Perugia, Italy.
Bruttomesso D; Department of Medicine, University of Padova, Padua, Italy.
Larosa M; Medical Affairs, Sanofi S.r.l., Milan, Italy.
Rossi MC; CORESEARCH, Center for Outcome Research and Clinical Epidemiology, Pescara, Italy.
Nicolucci A; CORESEARCH, Center for Outcome Research and Clinical Epidemiology, Pescara, Italy. nicolucci@coresearch.it.

Diabetes Ther ; 12(2): 509-525, 2021 Feb.

Article em En | MEDLINE | ID: mdl-33351177

Palavras-chave

Degludec 100 U/ml; Glargine 300 U/ml; Real-world evidence; Switch; Type 1 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article